1. Home
  2. VYX vs ALVO Comparison

VYX vs ALVO Comparison

Compare VYX & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$7.72

Market Cap

1.1B

Sector

N/A

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.06

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
ALVO
Founded
1881
2013
Country
United States
Luxembourg
Employees
13500
1460
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VYX
ALVO
Price
$7.72
$3.06
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$13.67
$8.00
AVG Volume (30 Days)
2.2M
638.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
N/A
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$6.02
$2.94
52 Week High
$14.67
$9.94

Technical Indicators

Market Signals
Indicator
VYX
ALVO
Relative Strength Index (RSI) 46.63 35.84
Support Level $7.67 $2.99
Resistance Level $8.41 $3.94
Average True Range (ATR) 0.41 0.17
MACD -0.10 -0.03
Stochastic Oscillator 17.66 0.98

Price Performance

Historical Comparison
VYX
ALVO

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: